<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ojra
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Rheumatology and Autoimmune Diseases
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2163-9914
   </issn>
   <issn publication-format="print">
    2164-005X
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ojra.2025.152006
   </article-id>
   <article-id pub-id-type="publisher-id">
    ojra-142706
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Epidemiological and Diagnostic Profiles of Chronic Inflammatory Rheumatism in a Regional University Hospital in Burkina Faso: A Three-Year Study (2020~2023)
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Camille
      </surname>
      <given-names>
       Sompougdou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Siébou
      </surname>
      <given-names>
       Hien
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abdourahmane
      </surname>
      <given-names>
       Ouangré
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Aimé Davy Sevy
      </surname>
      <given-names>
       Kenagnon
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Pascal Ismaël
      </surname>
      <given-names>
       Nikièma
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Fulgence
      </surname>
      <given-names>
       Kaboré
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Joëlle Wendlassida Stéphanie
      </surname>
      <given-names>
       Zabsonré/Tiendrebeogo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Dieu-Donné
      </surname>
      <given-names>
       Ouédraogo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aService de Rhumatologie, Centre Hospitalier Universitaire Régional de Ouahigouya (CHUR), Ouahigouya, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aUniversité Lédéa Bernard Ouédraogo, Ouahigouya, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aService de Néphrologie, CHUR de Ouahigouya, Ouahigouya, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff4">
    <addr-line>
     aService de Traumatologie Orthopédie, CHUR de Ouahigouya, Ouahigouya, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff5">
    <addr-line>
     aService de Rhumatologie, Centre Hospitalier Universitaire de Bogodogo, Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <aff id="aff6">
    <addr-line>
     aUniversité Joseph KI-ZERBO, Ouagadougou, Burkina Faso
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     11
    </day> 
    <month>
     04
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    02
   </issue>
   <fpage>
    54
   </fpage>
   <lpage>
    62
   </lpage>
   <history>
    <date date-type="received">
     <day>
      11,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      18,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      18,
     </day>
     <month>
      May
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Objective</b>
    <b>:</b> The objective is to describe the epidemiological and diagnostic profile of chronic inflammatory rheumatism (CIR) at the Ouahigouya Regional University Hospital.
    <b> Patients and Methods</b>
    <b>:</b> We conducted a descriptive cross-sectional study with retrospective data collection over a three-year period from April 1, 2020 to March 31, 2023. Patients received in rheumatology consultations or hospitalizations meeting the diagnostic criteria for chronic inflammatory rheumatism were included.
    <b> Results</b>
    <b>:</b> Forty patients were included in our study. There were 29 female patients and 11 male patients, resulting in a sex ratio of 0.37. The average age of patients was 46.05 ± 17.98 years, with extremes of 10 years and 76 years. The average disease duration was 29.87 ± 27.95 months, with extremes of 1 month to 120 months. Joint manifestations were mainly polyarthritis in 31 cases (77.5%) and polyarthralgia in eight cases (20%). Dermatological (17.5%), cardiovascular (12.5%) and haematological (10%) symptoms were the most frequent extra-articular symptoms. The pathological history was dominated by arterial hypertension in seven cases (17.5%), and diabetes mellitus in three cases (7.5%). The chronic inflammatory rheumatic diseases found were: rheumatoid arthritis in 24 patients (60%), indeterminate chronic inflammatory rheumatism disease in five patients (12.5%), systemic lupus erythematosus in three patients (7.5%), spondyloarthritis in two patients (5%), systemic scleroderma in two patients (5%), dermatomyositis in one patient (2.5%), secondary Gougerot-Sjögren’s syndrome in one patient (2.5%), remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in one patient (2.5%) and acute rheumatic fever in one patient (2.5%). 
    <b>Co</b>
    <b>nclus</b>
    <b>ion</b>
    <b>:</b> Our study shows that rheumatic fever is not rare in Ouahigouya. It is dominated by rheumatoid arthritis and indeterminate chronic inflammatory rheumatism diseases.
   </abstract>
   <kwd-group> 
    <kwd>
     Chronic Inflammatory Rheumatism
    </kwd> 
    <kwd>
      Rheumatoid Arthritis
    </kwd> 
    <kwd>
      Systemic Lupus Erythematosus
    </kwd> 
    <kwd>
      Sub-Saharan Africa
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>
    <xref ref-type="bibr" rid="scirp.142706-"></xref>Chronic inflammatory rheumatism (CIR) is a group of disorders that share joint manifestations and an autoimmune or autoinflammatory process as a pathogenic mechanism <xref ref-type="bibr" rid="scirp.142706-1">
     [1]
    </xref>.</p>
   <p>In Western countries, CIR is a public health problem. The prevalence of CIR in France is reported to be 1.55% <xref ref-type="bibr" rid="scirp.142706-2">
     [2]
    </xref>. Rheumatoid arthritis and spondyloarthritis are the most common CIR, each with a prevalence of 0.3% <xref ref-type="bibr" rid="scirp.142706-3">
     [3]
    </xref> <xref ref-type="bibr" rid="scirp.142706-4">
     [4]
    </xref>.</p>
   <p>Compared with the general population, CIR is associated with a high rate of morbidity and mortality <xref ref-type="bibr" rid="scirp.142706-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.142706-6">
     [6]
    </xref>. Mortality in CIR has been linked to cardiovascular, respiratory, and digestive diseases, as well as infections and cancers <xref ref-type="bibr" rid="scirp.142706-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.142706-6">
     [6]
    </xref>. These conditions can lead to varying degrees of functional disability <xref ref-type="bibr" rid="scirp.142706-7">
     [7]
    </xref>.</p>
   <p>In Sub-Saharan Africa, the available studies are predominantly hospital-based. CIR is likely underdiagnosed in these studies due to a scarcity of specialists and diagnostic resources, coupled with the limited financial means of the population <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref>-<xref ref-type="bibr" rid="scirp.142706-10">
     [10]
    </xref>. Hospital-based studies in Togo and Guinea reported 290 cases over 9 years and 339 cases over 18 months, respectively <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.142706-11">
     [11]
    </xref>.</p>
   <p>In Burkina Faso, a study conducted in the city of Ouagadougou identified 802 cases of CIR over a 14-year period <xref ref-type="bibr" rid="scirp.142706-12">
     [12]
    </xref>. The most prevalent CIRs were rheumatoid arthritis (434 patients, 51.61%), chronic indeterminate rheumatism (191 patients, 22.71%), systemic lupus erythematosus (71 patients, 8.44%) and spondyloarthritis (63 patients, 7.49 %) <xref ref-type="bibr" rid="scirp.142706-12">
     [12]
    </xref>.</p>
   <p>Rheumatology is a relatively new specialty in the northern region of Burkina Faso. The first rheumatology consultation at the regional university hospital in Ouahigouya took place on April 1, 2020. This hospital serves as the referral center for the northern region. Given the absence of prior studies on CIR in Ouahigouya, our work is of significant interest. The aim of our study was to investigate the epidemiological and diagnostic characteristics of chronic inflammatory rheumatism at the Ouahigouya regional university hospital.</p>
  </sec><sec id="s2">
   <title>2. Patients and Method</title>
   <p>
    <xref ref-type="bibr" rid="scirp.142706-"></xref>We conducted a descriptive cross-sectional study with retrospective collection from April 1, 2020 to March 31, 2023 in the rheumatology department of the Ouahigouya Regional University Hospital in Burkina Faso. Burkina Faso is a landlocked Sahelian country located in West Africa in the Niger loop. All patients meeting the diagnostic criteria for chronic inflammatory rheumatism were included. Patients with incomplete medical record of less than 75% and infectious, microcrystalline, endocrine, degenerative and paraneoplastic arthropathies were excluded. The data were collected using a survey form which included sociodemographic data, history, clinical data, immunological data (rheumatoid factors, anti-CCP antibodies, antinuclear antibodies, anti-native DNA antibodies, anti-ENA antibodies, anti-phospholipid antibodies), radiological data (standard X-ray, osteoarticular ultrasound, CT scan) and the final diagnosis. HLA B 27 typing was not sought in our study. Patient records were reviewed.</p>
   <p>The diagnoses of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic scleroderma (SS), dermatomyositis (DM), polymyositis (PM), spondyloarthritis and Gougerot-Sjögren’s syndrome (GSS) were based on the criteria set by the American College of Rheumatology (ACR) and the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) <xref ref-type="bibr" rid="scirp.142706-13">
     [13]
    </xref>-<xref ref-type="bibr" rid="scirp.142706-18">
     [18]
    </xref>. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome or benign acute oedematous polyarthritis of the elderly was adopted on the basis of the McCarty criteria <xref ref-type="bibr" rid="scirp.142706-19">
     [19]
    </xref>. The diagnosis of acute rheumatic fever (ARF) was based on the Jones criteria <xref ref-type="bibr" rid="scirp.142706-20">
     [20]
    </xref>. When no diagnostic criteria were met, the patient was considered to have indeterminate chronic inflammatory rheumatism. Autoantibodies were not tested in all patients.</p>
   <p>Confidentiality of information was ensured by anonymising the data collection forms. The study was conducted in accordance with the ethical recommendations of the Declaration of Helsinki.</p>
   <p>Data were entered and analysed using Epi Info 7.2.4.0 software.</p>
  </sec><sec id="s3">
   <title>3. Results</title>
   <p>
    <xref ref-type="bibr" rid="scirp.142706-"></xref>Forty patients were included in our study. There were 29 female patients (72.5%) and 11 male patients (27.5%) (sex ratio 0.37). The average age of patients was 46.05 ± 17.98 years, with extremes of 10 years and 76 years. Regarding marital status, 25 patients (62.5%) were married, 11 (27.5%) were single and 4 (10%) were widowed. These patients were housewives (32.5%), civil servants (27.5%), farmers (15%), informal sector workers (12.5%) and students (12.5%). The average disease duration was 29.87 ± 27.95 months, with extremes of 1 month and 120 months. The main reasons for consultation were arthritis in 77.5% of cases and arthralgia in 20%. <xref ref-type="table" rid="table1">
     Table 1
    </xref> summarises the distribution of patients according to the reason for consultation. The pain was inflammatory in 37 patients (92.5%), mechanical in two patients (5%) and mixed in one patient (2.5%). Extra-articular manifestations were primarily dermatological (17.5%), cardiovascular (12.5%) and haematological (10%). <xref ref-type="table" rid="table2">
     Table 2
    </xref> shows the distribution of patients according to extra-articular manifestations.</p>
   <table-wrap id="table1">
    <label>
     <xref ref-type="table" rid="table1">
      Table 1
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.142706-"></xref>Table 1. Distribution of patients according to the reason for consultation.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="40.18%"><p style="text-align:center"></p></td> 
      <td class="custom-bottom-td acenter" width="29.91%"><p style="text-align:center">Total</p></td> 
      <td class="custom-bottom-td acenter" width="29.91%"><p style="text-align:center">Percentage</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="40.18%"><p style="text-align:center">Polyarthritis</p></td> 
      <td class="custom-top-td acenter" width="29.91%"><p style="text-align:center">31</p></td> 
      <td class="custom-top-td acenter" width="29.91%"><p style="text-align:center">77.5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.18%"><p style="text-align:center">Polyarthralgia</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">8</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">20</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.18%"><p style="text-align:center">Rachialgia</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">6</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">15</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.18%"><p style="text-align:center">Buttock Pain</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">2</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.18%"><p style="text-align:center">Oligoarthralgia</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">1</p></td> 
      <td class="acenter" width="29.91%"><p style="text-align:center">2.5</p></td> 
     </tr> 
    </table>
   </table-wrap>
   <table-wrap id="table2">
    <label>
     <xref ref-type="table" rid="table2">
      Table 2
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.142706-"></xref>Table 2. Distribution of patients according to extra-articular manifestations.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="55.92%"><p style="text-align:center"></p></td> 
      <td class="custom-bottom-td acenter" width="15.10%"><p style="text-align:center">Total</p></td> 
      <td class="custom-bottom-td acenter" width="28.98%"><p style="text-align:center">Percentage</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="55.92%"><p style="text-align:center">Dermatological</p></td> 
      <td class="custom-top-td acenter" width="15.10%"><p style="text-align:center">7/40</p></td> 
      <td class="custom-top-td acenter" width="28.98%"><p style="text-align:center">17.5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Erythema</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">3/7</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">42.86</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Cutaneous Sclerosis</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">2/7</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">28.57</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Rheumatoid Nodule</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/7</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">14.28</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Alopecia</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/7</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">14.28</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Cardiovascular</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">5/40</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">12.5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Cardiac Dyspnea</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/5</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">20</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Palpitation</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/5</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">20</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Heart Failure</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/5</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">20</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Raynaud’s Phenomenon</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">2/5</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">40</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Haematological</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">4/40</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">10</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Adenopathy</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">2/4</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">50</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Anemia</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">2/4</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">50</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Neuropsychiatric</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">3/40</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">7.5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Headaches</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">2/3</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">66.67</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Convulsion</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/3</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">33.33</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Respiratory</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">2/40</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Cough</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/2</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">50</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Pulmonary Dyspnea</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/2</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">50</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Digestive</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/40</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">2.5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Dysphagia</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/1</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">100</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Muscular</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/40</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">2.5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="55.92%"><p style="text-align:center">Myositis</p></td> 
      <td class="acenter" width="15.10%"><p style="text-align:center">1/1</p></td> 
      <td class="acenter" width="28.98%"><p style="text-align:center">100</p></td> 
     </tr> 
    </table>
   </table-wrap>
   <p>
    <xref ref-type="bibr" rid="scirp.142706-"></xref>A family history of CIR was found in two patients (Rheumatoid arthritis in a mother and Rheumatoid arthritis in a sister). Other pathological antecedents and comorbidities were arterial hypertension in seven patients (17.5%), diabetes mellitus in three patients (7.5%), HIV infection (2.5%), dysthyroidism (2.5%) and recurrent angina (2.5%).</p>
   <p>Joint deformities were observed in eight patients, all diagnosed with rheumatoid arthritis (40%). Destructive radiographic lesions (erosion, carpitis) were noted in 14 patients (35%). 12 of the 14 patients had rheumatoid arthritis.</p>
   <p>
    <xref ref-type="bibr" rid="scirp.142706-"></xref>The chronic inflammatory rheumatism found was rheumatoid arthritis in 24 patients (60%), indeterminate chronic inflammatory rheumatism in five patients (12.5%), and systemic lupus erythematosus in three patients (7.5%). <xref ref-type="table" rid="table3">
     Table 3
    </xref> shows the distribution of patients by type of chronic inflammatory rheumatism.</p>
   <table-wrap id="table3">
    <label>
     <xref ref-type="table" rid="table3">
      Table 3
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.142706-"></xref>Table 3. Distribution of patients by type of chronic inflammatory rheumatism.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="29.53%"><p style="text-align:center"></p></td> 
      <td class="custom-bottom-td acenter" width="10.37%"><p style="text-align:center">Total</p></td> 
      <td class="custom-bottom-td acenter" width="15.96%"><p style="text-align:center">Percentage</p></td> 
      <td class="custom-bottom-td acenter" width="13.60%"><p style="text-align:center">Average Age</p></td> 
      <td class="custom-bottom-td acenter" width="10.48%"><p style="text-align:center">Type Gap</p></td> 
      <td class="custom-bottom-td acenter" width="20.06%"><p style="text-align:center">Sex Ratio (Male/Female)</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="29.53%"><p style="text-align:center">Rheumatoid Arthritis</p></td> 
      <td class="custom-top-td acenter" width="10.37%"><p style="text-align:center">24</p></td> 
      <td class="custom-top-td acenter" width="15.96%"><p style="text-align:center">60</p></td> 
      <td class="custom-top-td acenter" width="13.60%"><p style="text-align:center">47.96</p></td> 
      <td class="custom-top-td acenter" width="10.48%"><p style="text-align:center">16.55</p></td> 
      <td class="custom-top-td acenter" width="20.06%"><p style="text-align:center">0.41</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">ICIR*</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">5</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">12.5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">65.2</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">5.49</p></td> 
      <td class="acenter" width="20.06%"><p style="text-align:center">0.25</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">Systemic Lupus Erythematosus</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">3</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">7.5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">31.33</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">3.3</p></td> 
      <td class="acenter" width="20.06%"><p style="text-align:center">0/2</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">Systemic Scleroderma</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">2</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">32.5</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">2.5</p></td> 
      <td class="acenter" width="20.06%"><p style="text-align:center">0/2</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">Spondyloarthritis**</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">2</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">39.5</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">5.5</p></td> 
      <td class="acenter" width="20.06%"><p style="text-align:center">1</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">Dermatomyositis</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">1</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">2.5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">15</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="20.06%"><p style="text-align:center">0/1</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">Secondary Gougerot-Sjögren’s Syndrome</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">1</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">2.5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">15</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="20.06%"><p style="text-align:center">0/1</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">RS3PE Syndrome***</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">1</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">2.5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">66</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="20.06%"><p style="text-align:center">0/1</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.53%"><p style="text-align:center">Acute Rheumatic Fever</p></td> 
      <td class="acenter" width="10.37%"><p style="text-align:center">1</p></td> 
      <td class="acenter" width="15.96%"><p style="text-align:center">2.5</p></td> 
      <td class="acenter" width="13.60%"><p style="text-align:center">10</p></td> 
      <td class="acenter" width="10.48%"><p style="text-align:center">0</p></td> 
      <td class="custom-bottom-td acenter" width="20.06%"><p style="text-align:center">0/1</p></td> 
     </tr> 
    </table>
   </table-wrap>
   <p>Note: *ICIR: Indeterminate chronic inflammatory rheumatism; **Spondyloarthritis (ankylosing spondylitis, reactive arthritis); ***RS3PE: Remitting seronegative symmetrical synovitis with pitting edema.</p>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>We reported 40 cases of CIR over three years. The main CIRs encountered in our series were rheumatoid arthritis, indeterminate chronic inflammatory rheumatism, systemic lupus erythematosus, systemic scleroderma and spondyolarthritis.</p>
   <p>The epidemiological, sociodemographic and diagnostic characteristics of the patients included in our study were similar to those of other African series <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.142706-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.142706-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.142706-21">
     [21]
    </xref>.</p>
   <p>Similar to our findings, CIR seems to be less frequent in Sub-Saharan Africa, as reported in hospital-based studies <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.142706-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.142706-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.142706-21">
     [21]
    </xref>. Our data are significantly lower than the prevalence reported in France <xref ref-type="bibr" rid="scirp.142706-2">
     [2]
    </xref>. This could be explained by the fact that CIR is under-diagnosed in Africa due to a lack of specialists, diagnostic resources, poverty and reliance on traditional medicine.</p>
   <p>Rheumatoid arthritis was the most common form of CIR and was noted in 24 patients in our study. This finding is similar to both African and European studies <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.142706-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.142706-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.142706-21">
     [21]
    </xref> <xref ref-type="bibr" rid="scirp.142706-22">
     [22]
    </xref>. The African studies found 434 cases of rheumatoid arthritis in 14 years in Ouagadougou, 119 cases in 9 years in Lomé and 108 cases in 18 months in Conakry <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.142706-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.142706-12">
     [12]
    </xref>. In population-based studies in Africa, the prevalence of rheumatoid arthritis is 0.13% in Algeria, 0.6% in the Democratic Republic of Congo and 0.9% in the black population of South Africa <xref ref-type="bibr" rid="scirp.142706-23">
     [23]
    </xref>-<xref ref-type="bibr" rid="scirp.142706-25">
     [25]
    </xref>. This disparity in frequency could be due to differences in methodology, the duration of the different studies and the cultural and geographical diversity in Africa.</p>
   <p>
    <xref ref-type="bibr" rid="scirp.142706-"></xref>Systemic scleroderma appeared to be rare in Ouahigouya. Our data are corroborated by other African series <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.142706-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.142706-21">
     [21]
    </xref>. On the other hand, Erzer et al. showed in a meta-analysis that 1884 patients with systemic scleroderma in Sub-Saharan countries, 66% of whom were from South Africa <xref ref-type="bibr" rid="scirp.142706-26">
     [26]
    </xref>. The majority of publications came from South Africa. Systemic scleroderma is not rare in Sub-Saharan African countries, but its presentation differs from that of Caucasians <xref ref-type="bibr" rid="scirp.142706-26">
     [26]
    </xref>. The presentation of systemic scleroderma in Sub-Saharan Africa differs from that reported in Europe and America by frequent diffuse skin involvement, focal skin hypopigmentation and a high prevalence of anti-fibrillarin autoantibodies <xref ref-type="bibr" rid="scirp.142706-26">
     [26]
    </xref>. The majority of patients (66%) were reported in South Africa.</p>
   <p>Benign oedematous acute polyarthritis of the elderly or RS3PE syndrome was found in a 66-year-old male patient. This chronic inflammatory rheumatism has not been observed in other African series <xref ref-type="bibr" rid="scirp.142706-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.142706-9">
     [9]
    </xref> <xref ref-type="bibr" rid="scirp.142706-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.142706-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.142706-21">
     [21]
    </xref>. RS3PE syndrome is a rare chronic inflammatory rheumatic disease that occurs in people over 65 years of age, with a male predominance <xref ref-type="bibr" rid="scirp.142706-27">
     [27]
    </xref>. Its pathophysiology is unknown, but a number of hypotheses have been put forward. On the one hand, the decrease in suppressive/cytotoxic T cells and the increase in circulating Th1 cells are likely to promote the development of inflammation <xref ref-type="bibr" rid="scirp.142706-28">
     [28]
    </xref>. The finding that VEGF levels are higher than in healthy subjects should also be taken into account <xref ref-type="bibr" rid="scirp.142706-27">
     [27]
    </xref>. VEGF induces synovial inflammation and vascular permeability; this may account for the distal oedema that is so characteristic of this syndrome <xref ref-type="bibr" rid="scirp.142706-29">
     [29]
    </xref>.</p>
   <p>Our study is limited by our methodology. Retrospective data collection and monocentric recruitment expose us to recruitment bias. The use of traditional medicine and the management of CIR by other specialties may also introduce us to a possible bias in the recruitment of our patients. The impossibility of carrying out immunological examinations and magnetic resonance imaging (MRI) in Ouahigouya, coupled with the limited resources of the population, meant that a certain number of CIR could not be fully explored. However, further studies, particularly in population-based studies, are needed before the results can be generalised.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>Chronic inflammatory rheumatism is not rare in the town of Ouahigouya. They are numerous and diverse. This study also reflects the diagnostic problems caused by the unavailability of immunology laboratories in the town of Ouahigouya. Rheumatoid arthritis and indeterminate chronic inflammatory rheumatism were the most common CIR. Population studies are needed to gain a better understanding of the different CIRs.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.142706-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ralandison, S. (2012) Arthralgie chronique: Comment diagnostiquer un rhumatisme inflammatoire chronique? La Revue Médicale de Madagascar, 2, 79-89. 
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Assurance Maladie (2024) Effectif de patients par pathologie et par classe d’âge selon le sexe—2015 à 2022. &gt;https://www.assurance-maladie.ameli.fr/etudes-et-donnees/cartographie-effectif-patients-par-pathologie-age-sexe
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Guillemin, F., Saraux, A., Guggenbuhl, P., Roux, C.H., Fardellone, P., Le Bihan, E., et al. (2005) Prevalence of Rheumatoid Arthritis in France: 2001. Annals of the Rheumatic Diseases, 64, 1427-1430. &gt;https://doi.org/10.1136/ard.2004.029199
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Saraux, A., Guillemin, F., Guggenbuhl, P., Roux, C.H., Fardellone, P., Le Bihan, E., et al. (2005) Prevalence of Spondyloarthropathies in France: 2001. Annals of the Rheumatic Diseases, 64, 1431-1435. &gt;https://doi.org/10.1136/ard.2004.029207
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pina Vegas, L., Drouin, J., Dray-Spira, R. and Weill, A. (2023) Prevalence, Mortality, and Treatment of Patients with Rheumatoid Arthritis: A Cohort Study of the French National Health Data System, 2010-2019. Joint Bone Spine, 90, Article ID: 105460. &gt;https://doi.org/10.1016/j.jbspin.2022.105460
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kelty, E., Ognjenovic, M., Raymond, W.D., Inderjeeth, C.A., Keen, H.I., Preen, D.B., et al. (2022) Mortality Rates in Patients with Ankylosing Spondylitis with and without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study. The Journal of Rheumatology, 49, 688-693. &gt;https://doi.org/10.3899/jrheum.210909
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tobón, G.J., Youinou, P. and Saraux, A. (2010) The Environment, Geo-Epidemiology, and Autoimmune Disease: Rheumatoid Arthritis. Journal of Autoimmunity, 35, 10-14. &gt;https://doi.org/10.1016/j.jaut.2009.12.009
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kakpovi, K., Oniankitan, S., Tagbor, K., Kondian, K., Koffi-Tessio, V., Ataké, A., et al. (2022) Rhumatismes inflammatoires chroniques en consultation rhumatologique à Lomé (Togo). Rhumatologie Africaine Francophone, 3, 16-23. &gt;https://doi.org/10.62455/raf.v3i1.26
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kane, B.S., Ndongo, S., Ndiaye, A.A., Djiba, B., Niasse, M., Diack, N., et al. (2016) Maladies systémiques en médecine interne “Contexte Africain”: Aspects épidémiologiques et classification. La Revue de Médecine Interne, 37, A37. &gt;https://doi.org/10.1016/j.revmed.2016.04.237
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mijiyawa, M., Amanga, K., Oniankitan, O.I., Pitché, P. and Tchangaï-Walla, K. (1999) Les connectivites en consultation hospitalière à Lomé (Togo). La Revue de Médecine Interne, 20, 13-17. &gt;https://doi.org/10.1016/s0248-8663(99)83004-5
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kamisssoko, A.B., Diallo, M.L., Oniankitan, S., Baldé, N., Traoré, M., Yombouno, E., et al. (2020) Prise en charge des rhumatismes inflammatoires chroniques en guinée. Journal de Recherche Scientifique, 4, 137-144.
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tiendrébéogo, J.W.S., Kaboré, F., Sougué, C., Sankara, V., Zongo, E., Savadogo, B., et al. (2023) Epidemiology of Rheumatic Diseases: A Cohort of 23,550 Patients in Rheumatology Clinics in Burkina Faso. Clinical Rheumatology, 42, 371-376. &gt;https://doi.org/10.1007/s10067-022-06470-y
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kay, J. and Upchurch, K.S. (2012) ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria. Rheumatology, 51, vi5-vi9. &gt;https://doi.org/10.1093/rheumatology/kes279
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hochberg, M.C. (1997) Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis&amp;Rheumatism, 40, 1725-1725. &gt;https://doi.org/10.1002/art.1780400928
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., et al. (2013) Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Arthritis&amp;Rheumatology, 65, 2737-2747.
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Amor, B., Dougados, M. and Mijiyawa, M. (1990) Criteres de classification des Spondylarthropathies. Revue du Rhumatisme et des Maladies Ostéo-Articulaires, 57, 85-89.
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Guis, S., Mattei, J., Figarella-Branger, D. and Bendahan, D. (2010) Myopathies inflammatoires idiopathiques de l’adulte: Critères de diagnostic et de classification. Revue du Rhumatisme Monographies, 77, 99-102. &gt;https://doi.org/10.1016/j.monrhu.2010.01.011
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H.M., Alexander, E.L., Carsons, S.E., et al. (2002) Classification Criteria for Sjögren’s Syndrome: A Revised Version of the European Criteria Proposed by the American-European Consensus Group. Annals of the Rheumatic Diseases, 61, 554-558. &gt;https://doi.org/10.1136/ard.61.6.554
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     McCarty, D.J. (1985) Remitting Seronegative Symmetrical Synovitis with Pitting Edema. RS3PE Syndrome. JAMA, 254, 2763-2767. &gt;https://doi.org/10.1001/jama.1985.03360190069027
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gewitz, M.H., Baltimore, R.S., Tani, L.Y., Sable, C.A., Shulman, S.T., Carapetis, J., et al. (2015) Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography: A Scientific Statement from the American Heart Association. Circulation, 131, 1806-1818. &gt;https://doi.org/10.1161/cir.0000000000000205
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Singwe-Ngandeu, M., Meli, J., Ntsiba, H., Nouedoui, C., Yollo, A.V., Sida, M.B., et al. (2008) Rheumatic Diseases in Patients Attending a Clinic at a Referral Hospital in Yaounde, Cameroon. East African Medical Journal, 84, 404-409. &gt;https://doi.org/10.4314/eamj.v84i9.9549
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rat, A.-C. and El Adssi, H. (2013) Épidémiologie des maladies rhumatismales. EMC-Appareil locomoteur, 8, 1-15. &gt;https://doi.org/10.1016/s0246-0521(13)59644-6
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Slimani, S. and Ladjouze-Rezig, A. (2014) Prevalence of Rheumatoid Arthritis in an Urban Population of Algeria: A Prospective Study. Rheumatology, 53, 571-573. &gt;https://doi.org/10.1093/rheumatology/ket446
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Malemba, J.J., Mbuyi-Muamba, J.M., Mukaya, J., Bossuyt, X., Verschueren, P. and Westhovens, R. (2012) The Epidemiology of Rheumatoid Arthritis in Kinshasa, Democratic Republic of Congo—A Population-Based Study. Rheumatology, 51, 1644-1647. &gt;https://doi.org/10.1093/rheumatology/kes092
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Beighton, P., Solomon, L. and Valkenburg, H.A. (1975) Rheumatoid Arthritis in a Rural South African Negro Population. Annals of the Rheumatic Diseases, 34, 136-141. &gt;https://doi.org/10.1136/ard.34.2.136
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Erzer, J.N., Jaeger, V.K., Tikly, M. and Walker, U.A. (2020) Systemic Sclerosis in Sub-Saharan Africa: A Systematic Review. Pan African Medical Journal, 37, Article 176. &gt;https://doi.org/10.11604/pamj.2020.37.176.22557
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wendling, D., Verhoeven, F. and Prati, C. (2019) Le RS3PE syndrome ou polyarthrite aiguë œdémateuse bénigne du sujet âgé. Revue du Rhumatisme Monographies, 86, 195-198. &gt;https://doi.org/10.1016/j.monrhu.2018.10.005
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shimojima, Y., Matsuda, M., Ishii, W., et al. (2008) Analysis of Peripheral Blood Lymphocytes Using Flow Cytometry in Polymyalgia Rheumatica, RS3PE and Early Rheumatoid Arthritis. Clinical and Experimental Rheumatology, 26, 1079-1082.
    </mixed-citation>
   </ref>
   <ref id="scirp.142706-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Arima, K., Origuchi, T., Tamai, M., Iwanaga, N., Izumi, Y., Huang, M., et al. (2005) RS3PE Syndrome Presenting as Vascular Endothelial Growth Factor Associated Disorder. Annals of the Rheumatic Diseases, 64, 1653-1655. &gt;https://doi.org/10.1136/ard.2004.032995
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>